Transforming growth factor β can mediate apoptosis via the expression of TRAIL in human hepatoma cells

Transforming growth factor β (TGF-β) has been shown to induce apoptotic cell death in normal and transformed hepatocytes. However, the exact mechanism through which TGF-β induces cell death is still unknown. We examined a potential role of various death receptor/ligand systems in TGF-β-induced apopt...

Full description

Saved in:
Bibliographic Details
Main Authors: Herzer, Kerstin (Author) , Ganten, Tom M. (Author) , Schulze-Bergkamen, Henning (Author) , Koschny, Ronald (Author) , Krammer, Peter H. (Author) , Walczak, Henning (Author)
Format: Article (Journal)
Language:English
Published: 16 June 2005
In: Hepatology
Year: 2005, Volume: 42, Issue: 1, Pages: 183-192
ISSN:1527-3350
DOI:10.1002/hep.20757
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/hep.20757
Verlag, lizenzpflichtig, Volltext: https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.20757
Get full text
Author Notes:Kerstin Herzer, Tom M. Ganten, Henning Schulze‐Bergkamen, Anne Grosse‐Wilde, Ronald Koschny, Peter H. Krammer, and Henning Walczak
Description
Summary:Transforming growth factor β (TGF-β) has been shown to induce apoptotic cell death in normal and transformed hepatocytes. However, the exact mechanism through which TGF-β induces cell death is still unknown. We examined a potential role of various death receptor/ligand systems in TGF-β-induced apoptosis and identified the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) as a mediator of TGF-β-induced apoptosis in hepatoma cells. TGF-β-induced apoptosis is significantly impaired upon blockage of TRAIL. We show that TRAIL is upregulated in hepatoma cells upon treatment with TGF-β, whereas TRAIL receptor levels remain unchanged. In conclusion, our results provide evidence that the TRAIL system is critically involved in TGF-β-induced cell death in liver pathology.
Item Description:Gesehen am 04.03.2021
Physical Description:Online Resource
ISSN:1527-3350
DOI:10.1002/hep.20757